2019
DOI: 10.24123/kesdok.v3i2.4445
|View full text |Cite
|
Sign up to set email alerts
|

Untitled

Abstract: Abstract—MDI (metered-dose inhaler) containing Ipratropium Bromide is used to control COPD symptoms. Improper use can trigger unwanted effects, so it takes the role of pharmacists in helping explain how to use it. The purpose of this study was to determine the completeness of the explanation by pharmacists in pharmacies regarding how to use MDI containing ipratropium bromide. This research method is cross-sectional with purposive sampling, using an observation technique in the form of a checklist. The sample i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 6 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?